期刊文献+

原发性肾上腺淋巴瘤并颅内侵犯的临诊应对

Management of primary adrenal lymphoma with intracranial invasion
原文传递
导出
摘要 原发性肾上腺淋巴瘤(primary adrenal lymphoma,PAL)是一种罕见的结节外淋巴瘤。因其临床和影像学特点不典型,误诊率极高,确诊依靠组织病理学检查。患者常因影像学检查发现肾上腺意外瘤而在内分泌科就诊。PAL常伴有其他组织和器官侵犯,死亡率较高,预后较差。本文对1例原发性肾上腺淋巴瘤并颅内侵犯患者的临床特点进行分析,并对该病的发病机制、临床表现、诊断及治疗等进行文献复习。 Primary adrenal lymphoma(PAL)is a rare extranodular lymphoma.It is subject to misdiagnosis due to atypical clinical and imaging features.Histopathology is required to establish the diagnosis.Patients often present to the Endocrinology Department upon revelation of adrenal incidentalomas by imaging.PAL is often accompanied by invasion of other tissues and organs,with a high mortality rate and a poor prognosis.In this paper,the clinical features of a patient with primary adrenal lymphoma and intracranial invasion were summarized,and the pathogenesis,clinical manifestations,diagnosis and treatment of this disease were reviewed.
作者 季业 庄新娟 韩峻峰 周健 包玉倩 Ji Ye;Zhuang Xinjuan;Han Junfeng;Zhou Jian;Bao Yuqian(Department of Endocrinology and Metabolism,Shanghai Jiao Tong University Affiliated Sixth People′s Hospital,Shanghai Clinical Medical Center for Diabetes,Shanghai Diabetes Institute,Shanghai 200233,China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2023年第1期55-59,共5页 Chinese Journal of Endocrinology and Metabolism
关键词 原发性肾上腺淋巴瘤 肾上腺意外瘤 颅内侵犯 Primary adrenal lymphoma Adrenal incidentaloma Intracranial invasion
  • 相关文献

参考文献2

二级参考文献22

  • 1Santos GW, Sensenbrener L, Burke PJ, et al. Marrow transplantation in man following cyclophosphamide [ J ]. Transplant Proc,1971, 2:400-404.
  • 2Kumar S, Gupta RK, Bhake AS, et al. Cardiotoxic effects of high doses of cyclophosphamide in albino rats[ J ]. Arch Int Pharmacodyn Ther, 1992, 319:58-65.
  • 3Hopkins HA, Betsill WL, Hobson Jr AS, et al. Cyclophosphamideinduced cardiomyopathy in the rat [ J]. Cancer Treatment Reports,1982, 66(7): 1 521 -1 527.
  • 4Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity:characterising and avoiding the problem[ J]. Drugs, 1991,42 (5):781 - 795.
  • 5Colvin M, Hilton J. Pharmacology of cyclophosphamide and metabolites[J]. Cancer Treatment Reports, 1981, 65 ( Suppl. 3 ): S89- S95.
  • 6Kachel DL, Martin WJ 2nd. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury[ J]. J Pharmacol Exp Ther, 1994, 268(1): 42-46.
  • 7Mills BA, Roberts RW. Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature [ J ].Cancer, 1979,43:2 223 -2 226.
  • 8Steinherz LJ, Steinherz PJ, Mangiacasale D, et al. Cardiac changes with cyclophosphamide[ J]. Med Pediatr Oncol, 1981, 9: 417-422.
  • 9Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens [ J ]. Journal of Clinical Oncology,1991, 9(7): 1 215-1 223.
  • 10Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention [ J ]. Drug Saf, 2000, 22 (4):263 - 302.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部